These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25054064)

  • 1. The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma.
    Li M; Bolduc AR; Hoda MN; Gamble DN; Dolisca SB; Bolduc AK; Hoang K; Ashley C; McCall D; Rojiani AM; Maria BL; Rixe O; MacDonald TJ; Heeger PS; Mellor AL; Munn DH; Johnson TS
    J Immunother Cancer; 2014; 2():21. PubMed ID: 25054064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
    Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
    J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor Microenvironment.
    Johnson TS; Mcgaha T; Munn DH
    Adv Exp Med Biol; 2017; 1036():91-104. PubMed ID: 29275467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma.
    Zhai L; Bell A; Ladomersky E; Lauing KL; Bollu L; Nguyen B; Genet M; Kim M; Chen P; Mi X; Wu JD; Schipma MJ; Wray B; Griffiths J; Unwin RD; Clark SJ; Acharya R; Bao R; Horbinski C; Lukas RV; Schiltz GE; Wainwright DA
    Clin Cancer Res; 2021 Dec; 27(23):6514-6528. PubMed ID: 34479957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCC0208009 enhances the anti-tumor effects of temozolomide through direct inhibition and transcriptional regulation of indoleamine 2,3-dioxygenase in glioma models.
    Sun S; Du G; Xue J; Ma J; Ge M; Wang H; Tian J
    Int J Immunopathol Pharmacol; 2018; 32():2058738418787991. PubMed ID: 29993291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies.
    Monjazeb AM; Kent MS; Grossenbacher SK; Mall C; Zamora AE; Mirsoian A; Chen M; Kol A; Shiao SL; Reddy A; Perks JR; T N Culp W; Sparger EE; Canter RJ; Sckisel GD; Murphy WJ
    Clin Cancer Res; 2016 Sep; 22(17):4328-40. PubMed ID: 26979392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment.
    Munn DH; Sharma MD; Johnson TS; Rodriguez P
    Cancer Immunol Immunother; 2017 Aug; 66(8):1049-1058. PubMed ID: 28488123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model.
    Meng X; Du G; Ye L; Sun S; Liu Q; Wang H; Wang W; Wu Z; Tian J
    Int J Immunopathol Pharmacol; 2017 Sep; 30(3):215-226. PubMed ID: 28604143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.
    Holmgaard RB; Zamarin D; Munn DH; Wolchok JD; Allison JP
    J Exp Med; 2013 Jul; 210(7):1389-402. PubMed ID: 23752227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscale Reduced Graphene Oxide-Mediated Photothermal Therapy Together with IDO Inhibition and PD-L1 Blockade Synergistically Promote Antitumor Immunity.
    Yan M; Liu Y; Zhu X; Wang X; Liu L; Sun H; Wang C; Kong D; Ma G
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):1876-1885. PubMed ID: 30582788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IDO Targeting in Sarcoma: Biological and Clinical Implications.
    Nafia I; Toulmonde M; Bortolotto D; Chaibi A; Bodet D; Rey C; Velasco V; Larmonier CB; Cerf L; Adam J; Le Loarer F; Savina A; Bessede A; Italiano A
    Front Immunol; 2020; 11():274. PubMed ID: 32194552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment.
    Tanizaki Y; Kobayashi A; Toujima S; Shiro M; Mizoguchi M; Mabuchi Y; Yagi S; Minami S; Takikawa O; Ino K
    Cancer Sci; 2014 Aug; 105(8):966-73. PubMed ID: 24826982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy.
    Mellor AL; Chandler P; Lee GK; Johnson T; Keskin DB; Lee J; Munn DH
    J Reprod Immunol; 2002; 57(1-2):143-50. PubMed ID: 12385839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.
    Sharma MD; Baban B; Chandler P; Hou DY; Singh N; Yagita H; Azuma M; Blazar BR; Mellor AL; Munn DH
    J Clin Invest; 2007 Sep; 117(9):2570-82. PubMed ID: 17710230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific.
    Baban B; Chandler P; McCool D; Marshall B; Munn DH; Mellor AL
    J Reprod Immunol; 2004 Apr; 61(2):67-77. PubMed ID: 15063630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression.
    Noh KT; Son KH; Jung ID; Kang TH; Choi CH; Park YM
    J Biol Chem; 2015 May; 290(19):12394-402. PubMed ID: 25814664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma.
    Brown ZJ; Yu SJ; Heinrich B; Ma C; Fu Q; Sandhu M; Agdashian D; Zhang Q; Korangy F; Greten TF
    Cancer Immunol Immunother; 2018 Aug; 67(8):1305-1315. PubMed ID: 29959458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.
    Mellor AL; Sivakumar J; Chandler P; Smith K; Molina H; Mao D; Munn DH
    Nat Immunol; 2001 Jan; 2(1):64-8. PubMed ID: 11135580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
    Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy.
    Peng J; Xiao Y; Li W; Yang Q; Tan L; Jia Y; Qu Y; Qian Z
    Adv Sci (Weinh); 2018 May; 5(5):1700891. PubMed ID: 29876215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.